🇺🇸 FDA
Pipeline program

LP-98 20 mg

KB_LP-98_103

Phase 2 small_molecule active

Quick answer

LP-98 20 mg for HIV is a Phase 2 program (small_molecule) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Indication
HIV
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials